Clinical Trials Directory

Trials / Completed

CompletedNCT04005417

Meta-analysis of Stannous Fluoride Dentifrice and the Effects on Dentine Hypersensitivity

Bioavailable Stannous Fluoride Dentifrice Meta-Analyses: Effects on Dentine Hypersensitivity and Enamel Erosion

Status
Completed
Phase
Study type
Observational
Enrollment
1,036 (actual)
Sponsor
Procter and Gamble · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this 11 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) on dentine hypersensitivity versus a positive or negative control dentifrice.

Conditions

Interventions

TypeNameDescription
DRUGStannous fluoride dentifriceStannous fluoride (0.454%) dentifrice
DRUGPositive control dentifricePositive control dentifrice containing potassium nitrate or arginine.
DRUGNegative control dentifriceNegative control dentifrice containing either sodium fluoride (0.243%) or sodium monofluorophosphate (0.76%)

Timeline

Start date
2018-01-08
Primary completion
2018-11-30
Completion
2018-11-30
First posted
2019-07-02
Last updated
2019-07-02

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04005417. Inclusion in this directory is not an endorsement.